Related references
Note: Only part of the references are listed.PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer
Yanjun Gao et al.
ONCOLOGY REPORTS (2023)
Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis
Haolan Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)
Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)
S. M. Zahid Hosen et al.
FRONTIERS IN IMMUNOLOGY (2022)
Targeting hypoxic tumor microenvironment in pancreatic cancer
Jinxin Tao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms
Jan Korbecki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Hypoxia-induced FOXO4/LDHA axis modulates gastric cancer cell glycolysis and progression
Xiao-Hong Wang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
Dongjie Chen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more
Xiaodong Hao et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Interferon alpha-inducible protein 27 (IFI27) is a prognostic marker for pancreatic cancer based on comprehensive bioinformatics analysis
Shu Huang et al.
BIOENGINEERED (2021)
Unraveling LGALS1 as a Potential Immune Checkpoint and a Predictor of the Response to Anti-PD1 Therapy in Clear Cell Renal Carcinoma
Yan Li et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Aaron J. Grossberg et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
The Immune Microenvironment in Pancreatic Cancer
Magdalena Huber et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity
Andrea Padoan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Molecular subtypes of pancreatic cancer
Eric A. Collisson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy
Najah Albadari et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Checkpoint inhibitors in pancreatic cancer
Andreas Henriksen et al.
CANCER TREATMENT REVIEWS (2019)
ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer
Shigeru Hashimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Therapeutic developments in pancreatic cancer: current and future perspectives
John P. Neoptolemos et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Immunotherapy and Prevention of Pancreatic Cancer
Alexander H. Morrison et al.
TRENDS IN CANCER (2018)
Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer
David Balli et al.
CLINICAL CANCER RESEARCH (2017)
Data-Driven Prioritization and Review of Targets for Molecular-Based Theranostic Approaches in Pancreatic Cancer
Marjory Koller et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Radical antegrade modular pancreatosplenectomy versus standard procedure in the treatment of left-sided pancreatic cancer: A systemic review and meta-analysis
Feng Cao et al.
BMC SURGERY (2017)
Dermokine contributes to epithelial-mesenchymal transition through increased activation of signal transducer and activator of transcription 3 in pancreatic cancer
Chaohao Huang et al.
CANCER SCIENCE (2017)
HIF-1 at the crossroads of hypoxia, inflammation, and cancer
Kuppusamy Balamurugan
INTERNATIONAL JOURNAL OF CANCER (2016)
Modifiable and non-modifiable risk factors for pancreatic cancer: A review
Shallu Midha et al.
CANCER LETTERS (2016)
Metabolic phenotype of bladder cancer
Francesco Massari et al.
CANCER TREATMENT REVIEWS (2016)
Pancreatic cancer: yesterday, today and tomorrow
Daniel Ansari et al.
FUTURE ONCOLOGY (2016)
Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells
Oleksandr H. Minchenko et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
The Pancreas Cancer Microenvironment
Christine Feig et al.
CLINICAL CANCER RESEARCH (2012)
Radiosensitization and Stromal Imaging Response Correlates for the HIF-1 Inhibitor PX-478 Given with or without Chemotherapy in Pancreatic Cancer
David L. Schwartz et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Regulatory pathways in inflammation
Alberto Mantovani et al.
AUTOIMMUNITY REVIEWS (2007)
Hypoxia and angiogenesis in pancreatic cancer
Giuseppe Garcea et al.
ANZ JOURNAL OF SURGERY (2006)
HIF-1 and mechanisms of hypoxia sensing
GL Semenza
CURRENT OPINION IN CELL BIOLOGY (2001)